{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T17:58:36Z","timestamp":1779904716748,"version":"3.53.1"},"reference-count":75,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,29]],"date-time":"2025-03-29T00:00:00Z","timestamp":1743206400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,3,29]],"date-time":"2025-03-29T00:00:00Z","timestamp":1743206400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100014588","name":"Sanofi Pasteur","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014588","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Pneumococcal pneumonia is a major cause of morbidity and mortality among adults, especially those over 65\u00a0years of age. Understanding pneumococcal serotype-specific epidemiology in adults and elderly is necessary to inform vaccination policies and to guide the inclusion of serotypes in pneumococcal vaccines. This study aimed to identify the serotypes causing pneumonia in the elderly.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>A systematic review search was performed using the PubMed database from 1984 to 2020. The search was limited to articles written in English. Studies assessing pneumococcal pneumonia in adults were included. Meta-analysis, other systematic literature reviews and case-reports were excluded. Studies published after the introduction of vaccines (PPSV23 and PCVs) were included.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Forty studies were included. The most common serotype identified in the majority of the articles in adults was the serotype 3 followed by serotypes 19A and 11A. Those serotypes are included in current vaccines. Emergence of non-vaccine serotypes was also observed.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>Pneumococcal pneumonia remains a high burden in the elderly despite the existence of vaccines for many years. In 2019, nearly 1.4 million deaths were attributable to pneumococcal pneumonia (50% of whom were over 70\u00a0years old) and was the leading cause of deaths from infectious disease worldwide. The study highlights the importance of constant monitoring serotypes emerging in this population to better target vaccination strategies.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s12889-025-22164-x","type":"journal-article","created":{"date-parts":[[2025,3,30]],"date-time":"2025-03-30T01:52:44Z","timestamp":1743299564000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Systematic review on serotypes distribution of pneumococcal pneumonia in adults and the elderly"],"prefix":"10.1186","volume":"25","author":[{"given":"Fatiha","family":"Mrabt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Guedes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,29]]},"reference":[{"key":"22164_CR1","unstructured":"Global Health Estimates: Life expectancy and leading causes of death and disability. Disponible sur:\u00a0https:\/\/www.who.int\/data\/maternal-newborn-child-adolescent-ageing\/advisory-groups\/gama\/activities-of-gama. Cit\u00e9 21 f\u00e9vr 2021."},{"key":"22164_CR2","unstructured":"A visualized overview of global and regional trends in the leading causes of death and disability 2000-2019. Disponible sur:\u00a0https:\/\/www.who.int\/data\/stories\/leading-causes-of-death-and-disability-2000-2019-a-visual-summary. Cit\u00e9 21 f\u00e9vr 2021."},{"issue":"11","key":"22164_CR3","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1016\/S1473-3099(18)30310-4","volume":"18","author":"C Troeger","year":"2018","unstructured":"Troeger C, Blacker B, Khalil IA, Rao PC, Cao J, Zimsen SRM, et al. Estimates of the global, regional, and national morbidity, mortality, and aetiologies of lower respiratory infections in 195 countries, 1990\u20132016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Infect Dis. 2018;18(11):1191\u2013210.","journal-title":"Lancet Infect Dis"},{"key":"22164_CR4","unstructured":"Pneumonia. Disponible sur:\u00a0https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/pneumonia. Cit\u00e9 21 f\u00e9vr 2021."},{"key":"22164_CR5","unstructured":"Immunology and Vaccine-Preventable Diseases \u2013 Pink Book \u2013 Pneumococcal Disease. Disponible sur: https:\/\/www.cdc.gov\/vaccines\/pubs\/pinkbook\/downloads\/pneumo.pdf. Cit\u00e9 21 f\u00e9vr 2021."},{"issue":"8","key":"22164_CR6","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1086\/501354","volume":"42","author":"DN Fisman","year":"2006","unstructured":"Fisman DN, Abrutyn E, Spaude KA, Kim A, Kirchner C, Daley J. Prior pneumococcal vaccination is associated with reduced death, complications, and length of stay among hospitalized adults with community-acquired pneumonia. Clin Infect Dis. 2006;42(8):1093\u2013101.","journal-title":"Clin Infect Dis"},{"key":"22164_CR7","unstructured":"Invasive Pneumococcal Disease in Young Children Before Licensure of 13-Valent Pneumococcal Conjugate Vaccine --- United States, 2007. Disponible sur: https:\/\/www.cdc.gov\/mmwr\/preview\/mmwrhtml\/mm5909a1.htm. Cit\u00e9 21 f\u00e9vr 2021."},{"issue":"9","key":"22164_CR8","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1086\/521626","volume":"196","author":"LA Hicks","year":"2007","unstructured":"Hicks LA, Harrison LH, Flannery B, Hadler JL, Schaffner W, Craig AS, et al. Incidence of Pneumococcal Disease Due to Non-Pneumococcal Conjugate Vaccine (PCV7) Serotypes in the United States during the Era of Widespread PCV7 Vaccination, 1998\u20132004. J Infect Dis. 2007;196(9):1346\u201354.","journal-title":"J Infect Dis"},{"issue":"1","key":"22164_CR9","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1086\/648593","volume":"201","author":"T Pilishvili","year":"2010","unstructured":"Pilishvili T, Lexau C, Farley MM, Hadler J, Harrison LH, Bennett NM, et al. Sustained Reductions in Invasive Pneumococcal Disease in the Era of Conjugate Vaccine. The Journal of Infectious Diseases. J Infect Dis. 2010;201(1):32\u201341.","journal-title":"J Infect Dis"},{"issue":"7","key":"22164_CR10","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.3201\/eid1907.121830","volume":"19","author":"SS Richter","year":"2013","unstructured":"Richter SS, Heilmann KP, Dohrn CL, Riahi F, Diekema DJ, Doern GV. Pneumococcal Serotypes before and after Introduction of Conjugate Vaccines, United States, 1999\u201320111. Emerg Infect Dis juill. 2013;19(7):1074\u201383.","journal-title":"Emerg Infect Dis juill"},{"key":"22164_CR11","unstructured":"Licensure of a 13-Valent Pneumococcal Conjugate Vaccine (PCV13) and Recommendations for Use Among Children --- Advisory Committee on Immunization Practices (ACIP), 2010. Disponible sur: https:\/\/www.cdc.gov\/mmwr\/preview\/mmwrhtml\/mm5909a2.htm. Cit\u00e9 20 ao\u00fbt 2020."},{"key":"22164_CR12","unstructured":"Intervals Between PCV13 and PPSV23 Vaccines: Recommendations of the Advisory Committee on Immunization Practices (ACIP). Disponible sur:\u00a0https:\/\/www.cdc.gov\/mmwr\/preview\/mmwrhtml\/mm6434a4.htm. Cit\u00e9 20 ao\u00fbt 2020.\u00a0"},{"key":"22164_CR13","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.rmed.2018.02.007","volume":"137","author":"A Torres","year":"2018","unstructured":"Torres A, Cill\u00f3niz C, Blasi F, Chalmers JD, Gaillat J, Dartois N, et al. Burden of pneumococcal community-acquired pneumonia in adults across Europe: A literature review. Respir Med. 2018;137:6\u201313.","journal-title":"Respir Med"},{"key":"22164_CR14","doi-asserted-by":"crossref","unstructured":"Kobayashi M. Use of 15-Valent Pneumococcal Conjugate Vaccine and 20-Valent Pneumococcal Conjugate Vaccine Among U.S. Adults: Updated Recommendations of the Advisory Committee on Immunization Practices \u2014 United States, 2022. MMWR Morb Mortal Wkly Rep. 2022;71. Disponible sur:\u00a0https:\/\/www.cdc.gov\/mmwr\/volumes\/71\/wr\/mm7104a1.htm. Cit\u00e9 20 juin 2023.\u00a0","DOI":"10.15585\/mmwr.mm7104a1"},{"key":"22164_CR15","unstructured":"Vaccine Scheduler | ECDC. Disponible sur:\u00a0https:\/\/vaccine-schedule.ecdc.europa.eu\/Scheduler\/ByDisease?SelectedDiseaseId=25&SelectedCountryIdByDisease=-1. Cit\u00e9 9 janv 2025."},{"issue":"7","key":"22164_CR16","doi-asserted-by":"publisher","first-page":"e0131494","DOI":"10.1371\/journal.pone.0131494","volume":"10","author":"M van der Linden","year":"2015","unstructured":"van der Linden M, Falkenhorst G, Perniciaro S, Im\u00f6hl M. Effects of Infant Pneumococcal Conjugate Vaccination on Serotype Distribution in Invasive Pneumococcal Disease among Children and Adults in Germany. PLoS One. 2015;10(7):e0131494.","journal-title":"PLoS One"},{"key":"22164_CR17","doi-asserted-by":"crossref","unstructured":"Tin Tin Htar M, Christopoulou D, Schmitt HJ. Pneumococcal serotype evolution in Western Europe. BMC Infect Dis. 2015;15. Disponible sur: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC4606906\/. Cit\u00e9 22 f\u00e9vr 2021.","DOI":"10.1186\/s12879-015-1147-x"},{"issue":"3","key":"22164_CR18","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.vaccine.2017.11.054","volume":"36","author":"P De Wals","year":"2018","unstructured":"De Wals P, Lefebvre B, Deceuninck G, Longtin J. Incidence of invasive pneumococcal disease before and during an era of use of three different pneumococcal conjugate vaccines in Quebec. Vaccine. 2018;36(3):421\u20136.","journal-title":"Vaccine"},{"key":"22164_CR19","unstructured":"World Health Organization. (2010). Changing epidemiology of pneumococcal serotypes after introduction of conjugate vaccine: July 2010 report. Weekly Epidemiological Record [Relev\u00e9 \u00e9pid\u00e9miologique hebdomadaire]. 85(43):434\u2013436. Disponible sur: https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/241664\/WER8543_434-436.PDF?sequence=1&isAllowed=y. Cit\u00e9 13 juill 2020."},{"issue":"7","key":"22164_CR20","doi-asserted-by":"publisher","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","volume":"6","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the prisma statement. PLoS Med. 2009;6(7):e1000097.","journal-title":"PLoS Med"},{"issue":"6","key":"22164_CR21","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1016\/j.vaccine.2015.11.021","volume":"34","author":"A Shigayeva","year":"2016","unstructured":"Shigayeva A, Rudnick W, Green K, Tyrrell G, Demczuk WHB, Gold WL, et al. Association of serotype with respiratory presentations of pneumococcal infection, Ontario, Canada, 2003\u20132011. Vaccine. 2016;34(6):846\u201353.","journal-title":"Vaccine"},{"issue":"4","key":"22164_CR22","first-page":"325","volume":"56","author":"S Maraki","year":"2010","unstructured":"Maraki S, Mantadakis E, Samonis G. Serotype Distribution and Antimicrobial Resistance of Adult Streptococcus pneumoniae Clinical Isolates over the Period 2001\u20132008 in Crete. Greece CHE. 2010;56(4):325\u201332.","journal-title":"Greece CHE"},{"issue":"11","key":"22164_CR23","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1093\/infdis\/jit506","volume":"208","author":"RL Sherwin","year":"2013","unstructured":"Sherwin RL, Gray S, Alexander R, McGovern PC, Graepel J, Pride MW, et al. Distribution of 13-valent pneumococcal conjugate vaccine Streptococcus pneumoniae serotypes in US adults aged \u226550 years with community-acquired pneumonia. J Infect Dis. 2013;208(11):1813\u201320.","journal-title":"J Infect Dis"},{"issue":"33","key":"22164_CR24","doi-asserted-by":"publisher","first-page":"5386","DOI":"10.1016\/j.vaccine.2011.05.082","volume":"29","author":"SP Jacups","year":"2011","unstructured":"Jacups SP, Cheng A. The epidemiology of community acquired bacteremic pneumonia, due to Streptococcus pneumoniae, in the Top End of the Northern Territory, Australia\u2014Over 22 years. Vaccine. 2011;29(33):5386\u201392.","journal-title":"Vaccine"},{"issue":"28","key":"22164_CR25","doi-asserted-by":"publisher","first-page":"3275","DOI":"10.1016\/j.vaccine.2016.05.002","volume":"34","author":"CH van Werkhoven","year":"2016","unstructured":"van Werkhoven CH, Hollingsworth RC, Huijts SM, Bolkenbaas M, Webber C, Patterson S, et al. Pneumococcal conjugate vaccine herd effects on non-invasive pneumococcal pneumonia in elderly. Vaccine. 2016;34(28):3275\u201382.","journal-title":"Vaccine"},{"issue":"6","key":"22164_CR26","doi-asserted-by":"publisher","first-page":"1632","DOI":"10.1183\/09031936.00183614","volume":"45","author":"C Rodrigo","year":"2015","unstructured":"Rodrigo C, Bewick T, Sheppard C, Greenwood S, Mckeever TM, Trotter CL, et al. Impact of infant 13-valent pneumococcal conjugate vaccine on serotypes in adult pneumonia. European Respiratory Journal. Eur Respir J. 2015;45(6):1632\u201341.","journal-title":"Eur Respir J"},{"issue":"3","key":"22164_CR27","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1093\/jac\/dkq480","volume":"66","author":"A Domenech","year":"2011","unstructured":"Domenech A, Ardanuy C, Calatayud L, Santos S, Tubau F, Grau I, et al. Serotypes and genotypes of Streptococcus pneumoniae causing pneumonia and acute exacerbations in patients with chronic obstructive pulmonary disease. J Antimicrob Chemother. 2011;66(3):487\u201393.","journal-title":"J Antimicrob Chemother"},{"issue":"3","key":"22164_CR28","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/0002-9343(87)90751-0","volume":"83","author":"HL Forrester","year":"1987","unstructured":"Forrester HL, Jahnigen DW, Marc Laforce F. Inefficacy of pneumococcal vaccine in a high-risk population. Am J Med. 1987;83(3):425\u201330.","journal-title":"Am J Med"},{"key":"22164_CR29","doi-asserted-by":"crossref","unstructured":"Morgan AD, Rhind GB, Connaughton JJ, Calder MA. Pneumococcal serotyping and antigen detection in pneumococcal pneumonia of adults. J Infect. 1984;9(2):134\u20138.","DOI":"10.1016\/S0163-4453(84)90961-7"},{"issue":"2","key":"22164_CR30","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.rce.2012.09.011","volume":"213","author":"P Cardinal-Fern\u00e1ndez","year":"2013","unstructured":"Cardinal-Fern\u00e1ndez P, Garc\u00eda Gabarrot G, Echeverria P, Zum G, Hurtado J, Rieppi G. Clinical and microbiological aspects of acute community-acquired pneumonia due to Streptococcus pneumoniae. Rev Clin Esp (Barc). 2013;213(2):88\u201396.","journal-title":"Rev Clin Esp (Barc)"},{"issue":"2","key":"22164_CR31","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.bjid.2013.06.001","volume":"18","author":"A Fica","year":"2014","unstructured":"Fica A, Bunster N, Aliaga F, Olivares F, Porte L, Braun S, et al. Bacteremic pneumococcal pneumonia: serotype distribution, antimicrobial susceptibility, severity scores, risk factors, and mortality in a single center in Chile. Braz J Infect Dis avr. 2014;18(2):115\u201323.","journal-title":"Braz J Infect Dis avr"},{"issue":"4","key":"22164_CR32","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1111\/j.1440-1843.2006.00867.x","volume":"11","author":"K Oishi","year":"2006","unstructured":"Oishi K, Yoshimine H, Watanabe H, Watanabe K, Tanimura S, Kawakami K, et al. Drug-resistant genes and serotypes of pneumococcal strains of community-acquired pneumonia among adults in Japan. Respirology. 2006;11(4):429\u201336.","journal-title":"Respirology"},{"issue":"10","key":"22164_CR33","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1016\/j.jiac.2015.07.002","volume":"21","author":"K Akata","year":"2015","unstructured":"Akata K, Chang B, Yatera K, Kawanami T, Yamasaki K, Naito K, et al. Distribution and annual changes in Streptococcus pneumoniae serotypes in adult Japanese patients with pneumonia. J Infect Chemother. 2015;21(10):723\u20138.","journal-title":"J Infect Chemother"},{"issue":"7","key":"22164_CR34","doi-asserted-by":"publisher","first-page":"e103092","DOI":"10.1371\/journal.pone.0103092","volume":"9","author":"AN Hor\u00e1cio","year":"2014","unstructured":"Hor\u00e1cio AN, Lopes JP, Ramirez M, Melo-Cristino J. Infections for the PG for the S of S. Non-Invasive Pneumococcal Pneumonia in Portugal\u2014Serotype Distribution and Antimicrobial Resistance. PLoS One. 2014;9(7):e103092.","journal-title":"PLoS One"},{"issue":"6","key":"22164_CR35","doi-asserted-by":"publisher","first-page":"2729","DOI":"10.1128\/AAC.01546-10","volume":"55","author":"E P\u00e9rez-Trallero","year":"2011","unstructured":"P\u00e9rez-Trallero E, Marim\u00f3n JM, Larruskain J, Alonso M, Ercibengoa M. Antimicrobial Susceptibilities and Serotypes of Streptococcus pneumoniae Isolates from Elderly Patients with Pneumonia and Acute Exacerbation of Chronic Obstructive Pulmonary Disease\u25bf. Antimicrob Agents Chemother juin. 2011;55(6):2729\u201334.","journal-title":"Antimicrob Agents Chemother juin"},{"issue":"6","key":"22164_CR36","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1086\/381886","volume":"38","author":"J Aspa","year":"2004","unstructured":"Aspa J, Rajas O, Rodr\u00edguez de Castro F, Blanquer J, Zalacain R, Fenoll A, et al. Drug-Resistant pneumococcal pneumonia: clinical relevance and related factors. Clin Infect Dis. 2004;38(6):787\u201398.","journal-title":"Clin Infect Dis"},{"issue":"3","key":"22164_CR37","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.ram.2018.10.002","volume":"51","author":"G Echaniz-Aviles","year":"2019","unstructured":"Echaniz-Aviles G, Garza-Gonz\u00e1lez E, Rom\u00e1n-Mancha AL, Morf\u00edn-Otero R, Rodr\u00edguez-Noriega E, Ayala-Gayt\u00e1n JJ, et al. Clinical and microbiological characteristics of community-acquired pneumonia associated with Streptococcus pneumoniae in adult patients in Mexico. Revista Argentina de Microbiolog\u00eda. 2019;51(3):234\u201340.","journal-title":"Revista Argentina de Microbiolog\u00eda"},{"issue":"2","key":"22164_CR38","doi-asserted-by":"publisher","first-page":"163","DOI":"10.3109\/00365548809032433","volume":"20","author":"\u00c5 \u00d6rtqvist","year":"1988","unstructured":"\u00d6rtqvist \u00c5, Grepe A, Julander I, Kalin M. Bacteremic Pneumococcal Pneumonia in Sweden: Clinical Course and Outcome and Comparison with Non-bacteremic Pneumococcal and Mycoplasmal Pneumonias. Scandinavian J Infect Dis. 1988;20(2):163\u201371.","journal-title":"Scandinavian J Infect Dis"},{"issue":"6","key":"22164_CR39","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1017\/S0950268806006303","volume":"134","author":"L Qin","year":"2006","unstructured":"Qin L, Watanabe H, Yoshimine H, Guio H, Watanabe K, Kawakami K, et al. Antimicrobial susceptibility and serotype distribution of Streptococcus pneumoniae isolated from patients with community-acquired pneumonia and molecular analysis of multidrug-resistant serotype 19F and 23F strains in Japan. Epidemiol Infect d\u00e9c. 2006;134(6):1188\u201394.","journal-title":"Epidemiol Infect d\u00e9c"},{"issue":"1","key":"22164_CR40","doi-asserted-by":"publisher","first-page":"95","DOI":"10.4103\/ijmm.IJMM_16_132","volume":"35","author":"C Wattal","year":"2017","unstructured":"Wattal C, Goel N, Byotra SP. Prevalence of Pneumococcal Serotypes in Adults \u226550 Years of Age. Indian J Med Microbiol. 2017;35(1):95\u2013100.","journal-title":"Indian J Med Microbiol"},{"issue":"1","key":"22164_CR41","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1136\/thoraxjnl-2019-213725","volume":"75","author":"H Pick","year":"2020","unstructured":"Pick H, Daniel P, Rodrigo C, Bewick T, Ashton D, Lawrence H, et al. Pneumococcal serotype trends, surveillance and risk factors in UK adult pneumonia, 2013\u201318. Thorax. 2020;75(1):38\u201349.","journal-title":"Thorax"},{"issue":"20","key":"22164_CR42","doi-asserted-by":"publisher","first-page":"2687","DOI":"10.1016\/j.vaccine.2019.04.009","volume":"37","author":"E Sando","year":"2019","unstructured":"Sando E, Suzuki M, Furumoto A, Asoh N, Yaegashi M, Aoshima M, et al. Impact of the pediatric 13-valent pneumococcal conjugate vaccine on serotype distribution and clinical characteristics of pneumococcal pneumonia in adults: The Japan Pneumococcal Vaccine Effectiveness Study (J-PAVE). Vaccine. 2019;37(20):2687\u201393.","journal-title":"Vaccine"},{"issue":"6","key":"22164_CR43","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1136\/thoraxjnl-2011-201092","volume":"67","author":"T Bewick","year":"2012","unstructured":"Bewick T, Sheppard C, Greenwood S, Slack M, Trotter C, George R, et al. Serotype prevalence in adults hospitalised with pneumococcal non-invasive community-acquired pneumonia. Thorax. 2012;67(6):540\u20135.","journal-title":"Thorax"},{"issue":"3","key":"22164_CR44","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1378\/chest.130.3.800","volume":"130","author":"X Vall\u00e9s","year":"2006","unstructured":"Vall\u00e9s X, Marcos A, Pinart M, Pi\u00f1er R, Marco F, Mensa JM, et al. Hospitalized Community-Acquired Pneumonia Due to Streptococcus pneumoniae: Has Resistance to Antibiotics Decreased?. Chest. 2006;130(3):800\u20136.","journal-title":"Chest"},{"issue":"12","key":"22164_CR45","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.1093\/cid\/cit640","volume":"57","author":"M Luj\u00e1n","year":"2013","unstructured":"Luj\u00e1n M, Burgos J, Gallego M, Falc\u00f3 V, Bermudo G, Planes A, et al. effects of immunocompromise and comorbidities on pneumococcal serotypes causing invasive respiratory infection in adults: implications for vaccine strategies. Clin Infect Dis. 2013;57(12):1722\u201330.","journal-title":"Clin Infect Dis"},{"issue":"5","key":"22164_CR46","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.medcle.2015.09.001","volume":"146","author":"A Vila-Corcoles","year":"2016","unstructured":"Vila-Corcoles A, Ansa X, Ochoa-Gondar O, Satue E, de Diego C, Rodriguez-Blanco T. Pneumococcal pneumonia in adults 60 years or older: Incidence, mortality and prevention. Med Clin (English Edition). 2016;146(5):199\u2013202.","journal-title":"Med Clin (English Edition)"},{"issue":"5","key":"22164_CR47","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1183\/09031936.00176309","volume":"36","author":"M Luj\u00e1n","year":"2010","unstructured":"Luj\u00e1n M, Gallego M, Belmonte Y, Fontanals D, Vall\u00e8s J, Lisboa T, et al. Influence of pneumococcal serotype group on outcome in adults with bacteraemic pneumonia. Eur Respir J. 2010;36(5):1073\u20139.","journal-title":"Eur Respir J"},{"issue":"11","key":"22164_CR48","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1111\/j.1469-0691.2011.03692.x","volume":"18","author":"C Cill\u00f3niz","year":"2012","unstructured":"Cill\u00f3niz C, Ewig S, Polverino E, Mu\u00f1oz-Almagro C, Marco F, Gabarr\u00fas A, et al. Pulmonary complications of pneumococcal community-acquired pneumonia: incidence, predictors, and outcomes. Clin Microbiol Infect. 2012;18(11):1134\u201342.","journal-title":"Clin Microbiol Infect"},{"issue":"2","key":"22164_CR49","doi-asserted-by":"publisher","first-page":"95","DOI":"10.5603\/PiAP.2016.0007","volume":"84","author":"R Harat","year":"2016","unstructured":"Harat R, Alexander R, Gray S, Gutterman EM, Pluta J, Pride M, et al. Prospective, population-based surveillance of the burden of Streptococcus pneumoniae in community-acquired pneumonia in older adults, Chrzan\u00f3w County, Poland, 2010 to 2012. Advances in Respiratory Medicine. 2016;84(2):95\u2013103.","journal-title":"Advances in Respiratory Medicine"},{"issue":"1","key":"22164_CR50","doi-asserted-by":"publisher","first-page":"e0210520","DOI":"10.1371\/journal.pone.0210520","volume":"14","author":"MJ Choi","year":"2019","unstructured":"Choi MJ, Noh JY, Cheong HJ, Kim WJ, Kim MJ, Jang YS, et al. Spread of ceftriaxone non-susceptible pneumococci in South Korea: Long-term care facilities as a potential reservoir. PLoS One. 2019;14(1):e0210520.","journal-title":"PLoS One"},{"key":"22164_CR51","doi-asserted-by":"crossref","unstructured":"Benfield T, Skovgaard M, Sch\u00f8nheyder HC, Knudsen JD, Bangsborg J, \u00d8stergaard C, et al. Serotype Distribution in Non-Bacteremic Pneumococcal Pneumonia: Association with Disease Severity and Implications for Pneumococcal Conjugate Vaccines. PLoS One. 2013;8(8). Disponible sur:\u00a0https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC3751823\/. Cit\u00e9 13 janv 2021.","DOI":"10.1371\/journal.pone.0072743"},{"issue":"1","key":"22164_CR52","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s12879-015-0788-0","volume":"15","author":"K Elberse","year":"2015","unstructured":"Elberse K, van Mens S, Cremers AJ, Meijvis SC, Vlaminckx B, de Jonge MI, et al. Detection and serotyping of pneumococci in community acquired pneumonia patients without culture using blood and urine samples. BMC Infect Dis. 2015;15(1):56.","journal-title":"BMC Infect Dis"},{"key":"22164_CR53","doi-asserted-by":"crossref","unstructured":"Garcia-Vidal C, Ardanuy C, Tubau F, Viasus D, Dorca J, Li\u00f1ares J, et al. Pneumococcal pneumonia presenting with septic shock: host- and pathogen-related factors and outcomes. 2010. Disponible sur: https:\/\/thorax.bmj.com\/content\/65\/1\/77.long.","DOI":"10.1136\/thx.2009.123612"},{"issue":"8","key":"22164_CR54","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1093\/infdis\/jit375","volume":"208","author":"DM Weinberger","year":"2013","unstructured":"Weinberger DM, Harboe ZB, Viboud C, Krause TG, Miller M, M\u00f8lbak K, et al. Serotype-Specific Effect of Influenza on Adult Invasive Pneumococcal Pneumonia. J Infect Dis. 2013;208(8):1274\u201380.","journal-title":"J Infect Dis"},{"issue":"13","key":"22164_CR55","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1016\/j.vaccine.2014.01.035","volume":"32","author":"C Rodrigo","year":"2014","unstructured":"Rodrigo C, Bewick T, Sheppard C, Greenwood S, Trotter C, Slack M, et al. Clinical features of adults with seven-valent-conjugated-vaccine-serotype pneumococcal pneumonia. Vaccine. 2014;32(13):1460\u20135.","journal-title":"Vaccine"},{"issue":"12","key":"22164_CR56","doi-asserted-by":"publisher","first-page":"2162","DOI":"10.1007\/s00134-018-5444-x","volume":"44","author":"JP Bedos","year":"2018","unstructured":"Bedos JP, Varon E, Porcher R, Asfar P, Le Tulzo Y, Megarbane B, et al. Host\u2013pathogen interactions and prognosis of critically ill immunocompetent patients with pneumococcal pneumonia: the nationwide prospective observational STREPTOGENE study. Intensive Care Med. 2018;44(12):2162\u201373.","journal-title":"Intensive Care Med"},{"issue":"36","key":"22164_CR57","doi-asserted-by":"publisher","first-page":"5466","DOI":"10.1016\/j.vaccine.2019.05.003","volume":"37","author":"JJ LeBlanc","year":"2019","unstructured":"LeBlanc JJ, ElSherif M, Ye L, MacKinnon-Cameron D, Ambrose A, Hatchette TF, et al. Streptococcus pneumoniae serotype 3 is masking PCV13-mediated herd immunity in Canadian adults hospitalized with community acquired pneumonia: A study from the Serious Outcomes Surveillance (SOS) Network of the Canadian immunization research Network (CIRN). Vaccine. 2019;37(36):5466\u201373.","journal-title":"Vaccine"},{"issue":"6","key":"22164_CR58","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1136\/thoraxjnl-2012-203106","volume":"68","author":"P Naucler","year":"2013","unstructured":"Naucler P, Darenberg J, Morfeldt E, Ortqvist A, Henriques NB. Contribution of host, bacterial factors and antibiotic treatment to mortality in adult patients with bacteraemic pneumococcal pneumonia. Thorax juin. 2013;68(6):571\u20139.","journal-title":"Thorax juin"},{"issue":"11","key":"22164_CR59","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1128\/CVI.00259-14","volume":"21","author":"S Athlin","year":"2014","unstructured":"Athlin S, Kaltoft M, Slotved HC, Herrmann B, Holmberg H, Konradsen HB, et al. Association between serotype-specific antibody response and serotype characteristics in patients with pneumococcal pneumonia, with special reference to degree of encapsulation and invasive potential. Clin Vaccine Immunol. 2014;21(11):1541\u20139.","journal-title":"Clin Vaccine Immunol"},{"issue":"12","key":"22164_CR60","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.1016\/j.vaccine.2018.02.005","volume":"36","author":"P Daniel","year":"2018","unstructured":"Daniel P, Rodrigo C, Bewick T, Sheppard C, Greenwood S, McKeever TM, et al. Valent vaccine serotype pneumococcal community acquired pneumonia in adults in high clinical risk groups. Vaccine. 2018;36(12):1614\u201320.","journal-title":"Vaccine"},{"issue":"4","key":"22164_CR61","doi-asserted-by":"publisher","first-page":"e1001017","DOI":"10.1371\/journal.pmed.1001017","volume":"8","author":"S Flasche","year":"2011","unstructured":"Flasche S, Hoek AJV, Sheasby E, Waight P, Andrews N, Sheppard C, et al. Effect of pneumococcal conjugate vaccination on serotype-specific carriage and invasive disease in England: a cross-sectional study. PLoS Med. 2011;8(4):e1001017.","journal-title":"PLoS Med"},{"issue":"2","key":"22164_CR62","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1093\/infdis\/jir730","volume":"205","author":"JR Scott","year":"2012","unstructured":"Scott JR, Millar EV, Lipsitch M, Moulton LH, Weatherholtz R, Perilla MJ, et al. Impact of more than a decade of pneumococcal conjugate vaccine use on carriage and invasive potential in native American communities. J Infect Dis. 2012;205(2):280\u20138.","journal-title":"J Infect Dis"},{"issue":"8","key":"22164_CR63","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1086\/591966","volume":"47","author":"EV Millar","year":"2008","unstructured":"Millar EV, Watt JP, Bronsdon MA, Dallas J, Reid R, Santosham M, et al. Indirect Effect of 7-Valent Pneumococcal Conjugate Vaccine on Pneumococcal Colonization among Unvaccinated Household Members. Clin Infect Dis. 2008;47(8):989\u201396.","journal-title":"Clin Infect Dis"},{"issue":"11","key":"22164_CR64","doi-asserted-by":"publisher","first-page":"e00198","DOI":"10.1016\/j.heliyon.2016.e00198","volume":"2","author":"HC Slotved","year":"2016","unstructured":"Slotved HC, Dalby T, Harboe ZB, Valentiner-Branth P, de Casadevante VF, Espenhain L, et al. The incidence of invasive pneumococcal serotype 3 disease in the Danish population is not reduced by PCV-13 vaccination. Heliyon. 2016;2(11):e00198.","journal-title":"Heliyon"},{"issue":"29","key":"22164_CR65","doi-asserted-by":"publisher","first-page":"3840","DOI":"10.1016\/j.vaccine.2019.05.052","volume":"37","author":"PP Espa\u00f1a","year":"2019","unstructured":"Espa\u00f1a PP, Uranga A, Ruiz LA, Quintana JM, Bilbao A, Aramburu A, et al. Evolution of serotypes in bacteremic pneumococcal adult pneumonia in the period 2001\u20132014, after introduction of the pneumococcal conjugate vaccine in bizkaia (spain). Vaccine. 2019;37(29):3840\u20138.","journal-title":"Vaccine"},{"key":"22164_CR66","doi-asserted-by":"crossref","unstructured":"Yahiaoui RY, Bootsma HJ, den\u00a0Heijer CDJ, Pluister GN, John Paget W, Spreeuwenberg P, et al. Distribution of serotypes and patterns of antimicrobial resistance among commensal Streptococcus pneumoniae in nine European countries. BMC Infect Dis. 2018;18. Disponible sur: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC6116386\/. Cit\u00e9 21 f\u00e9vr 2021.","DOI":"10.1186\/s12879-018-3341-0"},{"issue":"6","key":"22164_CR67","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1093\/cid\/ciab307","volume":"73","author":"A Torres","year":"2021","unstructured":"Torres A, Men\u00e9ndez R, Espa\u00f1a PP, Fern\u00e1ndez-Villar JA, Marim\u00f3n JM, Cilloniz C, et al. The evolution and distribution of pneumococcal serotypes in adults hospitalized with community-acquired pneumonia in Spain using a serotype-specific urinary antigen detection test: the CAPA study, 2011\u20132018. Clin Infect Dis. 2021;73(6):1075\u201385.","journal-title":"Clin Infect Dis"},{"issue":"4","key":"22164_CR68","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/j.jinf.2020.07.035","volume":"81","author":"JA Suaya","year":"2020","unstructured":"Suaya JA, Mendes RE, Sings HL, Arguedas A, Reinert RR, Jodar L, et al. Streptococcus pneumoniae serotype distribution and antimicrobial nonsusceptibility trends among adults with pneumonia in the United States, 2009\u20122017. J Infect. 2020;81(4):557\u201366.","journal-title":"J Infect"},{"issue":"5","key":"22164_CR69","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1136\/thoraxjnl-2018-211767","volume":"74","author":"G Hanquet","year":"2019","unstructured":"Hanquet G, Krizova P, Valentiner-Branth P, Ladhani SN, Nuorti JP, Lepoutre A, et al. Effect of childhood pneumococcal conjugate vaccination on invasive disease in older adults of 10 European countries: implications for adult vaccination. Thorax. 2019;74(5):473\u201382.","journal-title":"Thorax"},{"key":"22164_CR70","unstructured":"Research C for BE and. VAXNEUVANCE. FDA. 2022. Disponible sur: https:\/\/www.fda.gov\/vaccines-blood-biologics\/vaccines\/vaxneuvance. Cit\u00e9 27 nov 2022."},{"key":"22164_CR71","unstructured":"Research C for BE and. PREVNAR 20. FDA. 2022. Disponible sur:\u00a0https:\/\/www.fda.gov\/vaccines-blood-biologics\/vaccines\/prevnar-20. Cit\u00e9 27 nov 2022."},{"issue":"3","key":"22164_CR72","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.coi.2011.04.002","volume":"23","author":"KL Moffitt","year":"2011","unstructured":"Moffitt KL, Malley R. Next Generation Pneumococcal Vaccines. Curr Opin Immunol juin. 2011;23(3):407\u201313.","journal-title":"Curr Opin Immunol juin"},{"issue":"1","key":"22164_CR73","doi-asserted-by":"publisher","first-page":"18977","DOI":"10.1038\/s41598-020-75691-5","volume":"10","author":"A L\u00f8chen","year":"2020","unstructured":"L\u00f8chen A, Croucher NJ, Anderson RM. Divergent serotype replacement trends and increasing diversity in pneumococcal disease in high income settings reduce the benefit of expanding vaccine valency. Sci Rep. 2020;10(1):18977.","journal-title":"Sci Rep"},{"key":"22164_CR74","unstructured":"Progress in Introduction of Pneumococcal Conjugate Vaccine \u2014 Worldwide, 2000\u20132012. Disponible sur:\u00a0https:\/\/www.cdc.gov\/mmwr\/preview\/mmwrhtml\/mm6216a4.htm. Cit\u00e9 21 f\u00e9vr 2021.\u00a0"},{"key":"22164_CR75","doi-asserted-by":"publisher","unstructured":"Bonten MJM, Huijts SM, Bolkenbaas M, Webber C, Patterson S, Gault S, et al. https:\/\/doi.org\/10.1056\/NEJMoa1408544. Massachusetts Medical Society; 2015 [cit\u00e9 13 juill 2020]. Polysaccharide Conjugate Vaccine against Pneumococcal Pneumonia in Adults. Disponible sur: https:\/\/www.nejm.org\/doi\/10.1056\/NEJMoa1408544","DOI":"10.1056\/NEJMoa1408544"}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-025-22164-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12889-025-22164-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-025-22164-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:27:17Z","timestamp":1743467237000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpublichealth.biomedcentral.com\/articles\/10.1186\/s12889-025-22164-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,29]]},"references-count":75,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["22164"],"URL":"https:\/\/doi.org\/10.1186\/s12889-025-22164-x","relation":{},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,29]]},"assertion":[{"value":"18 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable (no humans involved).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1194"}}